Clinical trial
Deferoxamine for the Treatment of Hemochromatosis
NCT00001203 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00001203 |
|---|---|
| Title | Deferoxamine for the Treatment of Hemochromatosis |
| Official title | Clinical Course of Patients With Transfusional Hemochromatosis on Deferoxamine |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Diabetes Mellitus, Heart Disease, Hemochromatosis, Thalassemia |
| Enrollment | 151 |
| Start date | Apr 22, 1985 |
| Completion | Nov 9, 2015 |
| First posted | Nov 4, 1999 |
| Last update posted | Dec 12, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: